Results 91 to 100 of about 6,030,066 (175)

Evaluation of first generation vaccines against human leishmaniasis and the implication of Leishmanin Skin Test (LST) response in disease prevalence [PDF]

, 2011
This study reports the detailed analysis of the data from ten different clinical trials of first generation prophylactic vaccines (FGV) against leishmaniasis.
Noazin, Sassan
core   +1 more source

In Vitro Effect of Methanolic Extract of Quercus infectoria Galls on Promastigotes and Amastigotes of Leishmania major (MRHO/IR/75/ER)

Medical Laboratory Journal, 2018
Background and objectives: Leishmania major is a flagellated parasitic protozoan that causes cutaneous leishmaniasis. Pentavalent antimony compounds are considered the first-line drugs in the treatment of cutaneous leishmaniasis.
Asghar Farghi Yamchi, Mansour Dabirzadeh, Yahya Maroufi   +2 more
doaj  

Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis

Human Vaccines & Immunotherapeutics, 2020
The leishmaniases are a collection of vector-borne parasitic diseases caused by a number of different Leishmania species that are distributed worldwide.
Beatriz Coutinho De Oliveira, Malcolm S. Duthie, Valéria Rêgo Alves Pereira   +2 more
doaj   +1 more source

The role of CD4+T cells in host protective responses against cutaneous Leishmaniasis using genome-wide transcriptomics. [PDF]

, 2013
Includes abstract.Includes bibliographical references.Leishmania major is a protozoan parasite and infection in the human host causes severe cutaneous Leishmaniasis.
Smith, Liezel C
core   +1 more source

Atypical Manifestations of Old World Cutaneous Leishmaniasis: A Systematic Review and Clinical Atlas of Unusual Clinical and Specific Anatomical Presentations

Health Science Reports
Background and Aims Cutaneous leishmaniasis (CL) represents the most common form of leishmaniasis. It imposes a significant medical burden due to long‐lasting ulcers and disfiguring scars, underscoring the need for comprehensive CL control strategies ...
Bahareh Abtahi‐Naeini, Seyed Naser Emadi, Zabihollah Shahmoradi, Mahsa Pourmahdi‐Boroujeni, Ali Saffaei, Fereshte Rastegarnasab   +5 more
doaj   +1 more source

Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis. [PDF]

J Antimicrob Chemother, 2023
Van Bocxlaer K, Dixon J, Platteeuw JJ, Van Den Heuvel D, Mcarthur KN, Harris A, Alavijeh M, Croft SL, Yardley V.   +8 more
europepmc   +1 more source

Evaluation of farnesol orally and topically against experimental cutaneous leishmaniasis: In -vivo analysis. [PDF]

PLoS One, 2023
Sharma H, Sehgal R, Jhacak S, Deshmukh K, Nada R.   +4 more
europepmc   +1 more source

Leishmaniases in Bolivia: comprehensive review and current status. [PDF]

, 2009
The leishmaniases are protozoan, zoonotic diseases transmitted to human and other mammal hosts by the bite of phlebotomine sandflies. Bolivia has the highest incidence of cutaneous leishmaniasis (CL) in Latin America (LA), with 33 cases per 100,000 ...
Delgado, R., Parrado, Rudy, Delgado, Raúl, García, A. L., García, Ana L, Reithinger, R., Rojas, E., Delgado, Ra\ufal, Reithinger, Richard, Dujardin, Jean-Claude, Dujardin, J. C., Parrado, R., Rojas, Ernesto, Garc\ueda, Ana L.   +13 more
core   +1 more source

Leishmania isoenzyme polymorphisms in Ecuador: Relationships with geographic distribution and clinical presentation [PDF]

, 2006
Background: Determinants of the clinical presentation of the leishmaniases are poorly understood but Leishmania species and strain differences are important.
Cooper Philip J, Masataka Korenaga, Marco Jorge D, Korenaga, Masataka, Rodrigo X Armijos, Hirotomo Kato, Paola A Barroso, Kato Hirotomo, Korenaga, M, Gomez, EA, Calvopina Manuel, Kato, Hirotomo, Hiroshi Uezato, Barroso, Paola A., Armijos, Rodrigo X., Cooper, PJ, Yoshihisa Hashiguchi, Shigeo Nonaka, Nonaka Shigeo, Gomez Eduardo A, Manuel Calvopina, Marco, Jorge D., Kato, H, Barroso Paola A, Mimori, Tatsuyuki, Armijos, RX, Hashiguchi, Y, Nonaka, Shigeo, Eduardo A Gomez, Calvopina, M, Marco, JD, Korenaga Masataka, Tatsuyuki Mimori, Uezato, H, Jorge D Marco, Gomez, Eduardo A., Calvopina, Manuel, Mimori Tatsuyuki, Manuel Calvopina, Uezato Hiroshi, Cooper, Philip J., Hashiguchi, Yoshihisa, Mimori, T, Philip J Cooper, Nonaka, S, Uezato, Hiroshi, Armijos Rodrigo X, Barroso, PA, Hashiguchi Yoshihisa   +48 more
core   +2 more sources

Immunity and immunosuppression in experimental visceral leishmaniasis

Brazilian Journal of Medical and Biological Research, 2004
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is a form in which the inner organs are affected. Since knowledge about immunity in experimental visceral leishmaniasis is poor, we present here a review on
Goto H., Lindoso J.A.L.
doaj